In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Graceway Pharmaceuticals LLC

Division of Bausch Health Companies Inc.
www.gracewaypharma.com

Latest From Graceway Pharmaceuticals LLC

Xenon Down On Novel Acne Treatment Failure

Xenon Pharmaceuticals' attempts to treat acne with a SCD-1 inhibitor have met with failure at the Phase II stage, casting doubt on the therapeutic strategy and wiping more than 50% of the company's share price.

Clinical Trials Research & Development

Valeant Continues Buying Spree With $2.6B Acquisition Of Medicis

The specialty pharma adds to its dermatology portfolio with a proposed acquisition of Scottsdale, Ariz.-based Medicis.

BioPharmaceutical Business Strategies

Armstrong Juggles Reformulating Primatene Mist, Pushing To Sell Existing Inventory

Armstrong Pharmaceuticals plans to submit in the fourth quarter an NDA to FDA for an OTC asthma inhaler reformulated without chlorofluorocarbon as a propellant. The House Energy and Power Subcommittee proposes allowing the firm to sell its remaining inventory of CFC-containing Primatene Mist.

BioPharmaceutical Consumer

Armstrong Juggles Reformulating Primatene Mist, Pushing To Sell Existing Inventory

Armstrong Pharmaceuticals plans to submit in the fourth quarter an NDA to FDA for an OTC asthma inhaler reformulated without chlorofluorocarbon as a propellant. The House Energy and Power Subcommittee proposes allowing the firm to sell its remaining inventory of CFC-containing Primatene Mist.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Gynecological, Urological
  • Respiratory, Pulmonary
  • Alias(es)
  • Graceway Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Jefferson J Gregory, Chmn. & CEO
    Brian G Shrader, CFO
    Michael T Nordsiek, EVP, Prod. Dev.
    David D Fadness, SVP, Sales & Mktg.
  • Contact Info
  • Graceway Pharmaceuticals LLC
    340 Martin Luther King Jr. Blvd.
    Ste. 500
    Bristol, TN
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register